Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Eastern Cooperative Oncology Group
SpeciCare
Guangzhou Medical University